NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioConsortia, Inc.

BioConsortia, Inc.

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://bioconsortia.com/

Last Round

VC Round

Aug 1, 2025

Total Funding Raised

$49M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioConsortia, Inc. is an agricultural biotechnology company that develops microbial products to protect plants, enhance fertility, and increase crop yields.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

agricultural biotechnologymicrobial productsbiopesticidesbiostimulantsagtechbiological crop protectionmicrobial consortianematicidesfungicidesadvanced microbial selectionAMSsustainable agriculturebiologicalsmicrobiome analysiscrop yield enhancementagribusiness partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioConsortia, Inc. Comparables

Compare BioConsortia, Inc. with similar companies based on industry and business-model similarity.

BioConsortia, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aphea.Bio
82%
Kula Bio
78%
Micropep
77%
View all Comparables

BioConsortia, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 1, 2025
VC RoundApr 1, 2024
VC RoundApr 19, 2023
Series DMar 27, 2018
Series CNov 8, 2016
Series B
Apr 7, 2014
View all Funding Rounds

Key People

Founding team and executive leadership

Marcus Meadows-Smith

CEO

Executive Team

BioConsortia, Inc. Investors

Notable investors and investment history

BioConsortia, Inc. investors
InvestorRounds
Square 1 BankDebt
Khosla VenturesSeries B, Series D, Series C, Seed
Otter CapitalSeries B, Series C, VC Round, Series D
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2025

    $15M round led by Otter Capital.

  • Mar 27, 2018

    $10M round led by Otter Capital.

View all signals

BioConsortia, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioConsortia, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioConsortia, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDavis, California
Employee Range50
Year Founded2014
Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.